Medication Use and Health Care Utilization After a Cost-sharing Increase in Schizophrenia: A Nationwide Analysis.

"A.H.’s work was partly funded by a grant from the Borg Foundation. J.T., H.T., and A.T. have participated in research projects funded by grants from Janssen-Cilag and Eli Lilly to their employing institution. H.T. reports personal fees from Janssen-Cilag. J.T. reports personal fees from the Finnish Medicines Agency (Fimea), European Medicines Agency (EMA), Eli Lilly, Janssen-Cilag, Lundbeck, and Otsuka, is a member of the advisory board for Lundbeck, and has received grants from the Stanley Foundation and Sigrid Jusélius Foundation."

"Funded by the Social Insurance Institution of Finland (grant 15/26/2018) and Finnish Ministry of Social Affairs and Health through the developmental fund for Niuvanniemi Hospital. A.H.’s work was partly funded by a grant from the Borg Foundation. J.T., H.T., and A.T. have participated in research projects funded by grants from Janssen-Cilag and Eli Lilly to their employing institution. H.T. reports personal fees from Janssen-Cilag. J.T. reports personal fees from the Finnish Medicines Agency (Fimea), European Medicines Agency (EMA), Eli Lilly, Janssen-Cilag, Lundbeck, and Otsuka, is a member of the advisory board for Lundbeck, and has received grants from the Stanley Foundation and Sigrid Jusélius Foundation."